STOCK TITAN

Tilray Brands (TLRY) Stock News, Aug-Sep 2022

TLRY Nasdaq

Welcome to our dedicated page for Tilray Brands news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on Tilray Brands stock.

Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company spanning cannabis, craft beverages, hemp-based foods and wellness products. News about TLRY commonly covers product launches, brand refreshes and retail distribution across beverage and food subsidiaries such as BrewDog, 10 Barrel Brewing, SweetWater Brewing Company, Widmer Brothers Brewing and Manitoba Harvest.

Company updates also address Tilray Medical, international medical cannabis markets, Canadian adult-use and medical cannabis activity, quarterly operating results, acquisitions and capital actions. Recurring coverage links Tilray’s cannabis platform with its beverage and wellness portfolio across North America, Europe and other international markets.

Rhea-AI Summary

Tilray Brands, Inc. (Nasdaq: TLRY) announced it will release its financial results for Q1 fiscal 2023, ending August 31, 2022, on October 7, 2022, at 8:30 AM Eastern Time. A live audio webcast will discuss these results, accessible via the company's website. Investors can submit questions for the executive team until October 6, 2022, through the shareholder Q&A platform, Say Technologies. Tilray operates globally in the cannabis and consumer packaged goods sectors, committed to enhancing consumer well-being through its diverse product portfolio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.86%
Tags
-
Rhea-AI Summary

Tilray Brands has received approval from the Italian Ministry of Health to import and distribute its medical cannabis oral solution THC25 through its division, FL Group. This approval signifies a critical expansion into the Italian market, where it's expected to enhance patient access to medical cannabis. Tilray Medical operates in 22 countries and is known for its EU-GMP certified products. The company emphasizes its commitment to quality and responsible cannabis regulations, aiming to meet patient needs effectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.04%
Tags
none
-
Rhea-AI Summary

Tilray Brands announces the launch of RIFF Drumsticks, a new range of premium infused pre-rolls, available across Ontario. Released on September 15, 2022, these limited-edition products are made with Granddaddy Purp whole flower, offering enhanced THC potency and fruity aromas. The unique pre-rolls are rolled in unbleached paper, dipped in distillate, and coated in kief for an elevated experience. The RIFF brand aims to connect with cannabis consumers seeking flavorful and potent products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
Rhea-AI Summary

Tilray Brands, Inc. announced the renewal and expansion of Breckenridge Distillery's distribution agreement with Republic National Distributing Company (RNDC). This agreement allows for direct access to RNDC’s extensive network covering 38 states and the District of Columbia. Breckenridge Distillery, known for its award-winning spirits, including bourbon whiskey, aims to accelerate brand growth through this partnership. Breckenridge’s products have received numerous accolades, enhancing the distillery's profile and market reach.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
none
-
Rhea-AI Summary

Tilray Brands (Nasdaq: TLRY) has initiated a policy roundtable with German regulators to discuss adult-use cannabis legalization. The meeting featured German Drug Commissioner Burkhard Blienert, who announced a draft bill for legalization expected soon. Tilray aims to leverage its expertise to support this legislation, emphasizing product quality and safety. The company has a strong history in the cannabis sector, being the first to export medical cannabis from North America to the EU. Tilray's operations in Germany include EU-GMP certified production facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.65%
Tags
none
-
Rhea-AI Summary

Tilray Brands (Nasdaq: TLRY) has announced the expansion of its Good Supply cannabis portfolio, introducing new high-potency concentrates: Jean Guy Badder, Pineapple Express Hash Bats, and Orange Frost Live Resin. These products highlight the brand's commitment to quality and consumer experience, offering enhanced potency and flavor. Additionally, the launch of two new strains, Monkey Butter and Sweet Berry Kush, is set to reach new sizes and provinces, following strong demand. Good Supply remains a prominent brand in Canada’s cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.79%
Tags
none
Rhea-AI Summary

Tilray Brands has expanded its medical cannabis portfolio in Canada with new products under the Tilray and Aphria brands. Notably, it introduced CannaPoints, a program designed to support patients in their medical cannabis journey. The product line includes high-THC strains such as Tilray Sinaloa Gold and Aphria Sherbet Cookies, catering to diverse patient needs. Additionally, Tilray Medical partnered with Strainprint to enhance patient experience through the CannaPoints program, which guides users in exploring cannabis products and tracking their effects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.57%
Tags
none
-
Rhea-AI Summary

Tilray Medical, a division of Tilray Brands (Nasdaq: TLRY), has received approval from the Natural Health Science Foundation (NHSF) for its CBD100 product to be utilized in clinical trials in Australia and New Zealand. This verification highlights Tilray’s commitment to quality and safety in medical cannabis. The NHSF approval confirms that Tilray Purified Oral Solution meets rigorous standards for reproducibility and scientific validity. Additionally, the New Zealand Ministry of Health has verified product quality, further establishing Tilray Medical as a trusted provider in the region.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
none
-
Rhea-AI Summary

Tilray Brands has received approval from the Polish Ministry of Health to distribute its Tilray branded medical cannabis products in Poland, enhancing its European market presence.

Tilray Medical, which operates in 21 countries, focuses on providing high-quality THC and CBD products to patients. The company has established partnerships with local pharmaceutical companies to facilitate pharmacy distribution, allowing patients to obtain prescriptions through their doctors.

Tilray continues to advocate for patient access to reliable medical cannabis across Europe.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.45%
Tags
none
Rhea-AI Summary

Breckenridge Distillery has announced the release of two limited-edition Mile High Bourbon Blends, launching on August 8, 2022. This collaboration with the Denver Broncos features alumni Jake Plummer and Karl Mecklenburg blending bourbons that encapsulate unique flavor profiles. The blends, encased in commemorative bottles, celebrate the Broncos' legacy. The first blend received accolades, including Best American Blended Whiskey. Breckenridge Distillery, known for its award-winning spirits, was acquired by Tilray Brands, Inc. in December 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.87%
Tags
none

FAQ

What is the current stock price of Tilray Brands (TLRY)?

The current stock price of Tilray Brands (TLRY) is $3.99 as of September 19, 2026.

What is the market cap of Tilray Brands (TLRY)?

The market cap of Tilray Brands (TLRY) is approximately 560.3M.